trial

The Effects of Prebiotics on Cognitive Functioning and Weight Gain in Psychosis

NCTId NCT03153046
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 39 (actual)
Sponsored by University of Oxford
Primary completion 2018-09-30
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
39 (actual)
Study type
Interventional
Allocation
Randomized
Model
Crossover
Masking
Double
Start
2017-05-08
Primary completion
2018-09-30
Eligibility
ALL · 18 Years · 60 Years

Interventions & indications

Drugs
prebioticsMaltodextrin

Sponsors

University of OxfordLead Sponsor
Clasado Biosciences LtdCollaborator

Investigators

1
Belinda Lennox, MDPrincipal Investigator

Sites

1 total
Oxford, United Kingdom

Facts & assertions

4 sourced
Enrollment
39
Phase
NA
Primary Completion Date
2018-09-30
Status
COMPLETED
relationships
The graph out of here
drug
prebiotics
drug
Maltodextrin
drug
lead_sponsor
University of Oxford
company
collaborator
Clasado Biosciences Ltd
company
indication
Schizophrenia
indication
Schizophrenia
indication
Weight Gain
indication
investigator
Belinda Lennox, MD
person